Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Plant stem cells could be fruitful source of low-cost cancer drug

October 25, 2010 1:32 pm | by EurekAlert | News | Comments

(University of Edinburgh) A popular cancer drug could be produced cheaply and sustainably using stem cells derived from trees, a study suggests.

Allergies and wheezing illnesses in childhood may be determined in the womb

October 25, 2010 11:34 am | by EurekAlert | News | Comments

(University of Southampton) A child's chances of developing allergies or wheezing is related to how he or she grew at vital stages in the womb, according to scientists from the University of Southampton.

Discovery of taste receptors in the lungs could help people with asthma breathe easier

October 24, 2010 11:31 am | by EurekAlert | News | Comments

(University of Maryland Medical Center) Taste receptors in the lungs? Researchers at the University of Maryland School of Medicine in Baltimore have discovered that bitter taste receptors are not just located in the mouth but also in human lungs. What they learned about the role of the...

Advertisement

Studies: Pneumonia is misdiagnosed on patient readmissions

October 22, 2010 9:32 am | by EurekAlert | News | Comments

(Henry Ford Health System) Patients were misdiagnosed with pneumonia at an alarming rate when they were readmitted to the hospital shortly after a previous hospitalization for the same illness, according to two Henry Ford Hospital companion studies.

Pharmaxis Announces Positive Combined Phase 3 Cystic Fibrosis Trial Results

October 22, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

BALTIMORE, Oct. 22 /- Pharmaceutical company Pharmaxis (ASX: PXS) today announced significant results of pooled data from its two large scale six month Phase III trials of Bronchitol (inhaled mannitol) in people with cystic fibrosis. The combined results have been presented for the first...

Actavis Inc. Issues a Voluntary Recall of 18 Lots of Fentanyl Transdermal System 25 mcg/h

October 21, 2010 8:32 am | by Bio-Medicine.Org | News | Comments

MORRISTOWN, N.J., Oct. 21 /- Actavis Inc. today announced a voluntary recall to the wholesale and retail levels only of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches manufactured for Actavis by Corium International in the United States. Actavis identified one lot of 25...

Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix™ Biliary Stents

October 21, 2010 5:31 am | by Boston Scientific | News | Comments

Latest innovation in plastic biliary stent technology includes features for enhanced deliverability, efficiency and procedural control

New Choices for Colon Cancer Patients

October 20, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

SARASOTA, Fla., Oct. 20 /- Riley Powell taught high school English, and spent her summers training horses at a nearby dude ranch.  When she noticed blood in her stool, she thought it was hemorrhoids, from spending so many hours on horseback.  But when it persisted, she saw her...

Advertisement

New ratings of American hospitals released with quality study by HealthGrades

October 19, 2010 10:32 pm | by EurekAlert | News | Comments

(HealthGrades) A new independent study by HealthGrades of patient outcomes at America's hospitals found that patients at 5-star rated hospitals had a 72 percent lower risk of dying compared with patients at 1-star-rated hospitals -- an enormous gap that has held steady over the past years...

Mylan Declares Quarterly Preferred Stock Dividend

October 19, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Oct. 19 /- Mylan Inc. (Nasdaq: MYL ) today announced that in accordance with its 2.139 million preferred stock issuance, the company has declared its quarterly dividend of $16.25 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per...

Reportlinker Adds Lung Cancer Drug Futures

October 19, 2010 12:33 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Oct. 19 /- Reportlinker.com announces that a new market research report is available in its catalogue: Lung Cancer Drug Futures http://www.reportlinker.com/p0315763/Lung-Cancer-Drug-Futures.html AN EXCEPTIONALLY COST EFFECTIVE SERVICE INCLUDING FORMATS TO MEET EVERY INFORMATION...

Baltimore to Host Largest Gathering of Cystic Fibrosis Scientists and Clinicians in the World

October 19, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

BETHESDA, Md., Oct. 19 /PRNewswire-USNewswire/ -- In the largest meeting of its kind, nearly 4,000 doctors, scientists, researchers and caregivers will meet in Baltimore, Md., Oct. 21 –23, 2010, to present the latest information and advancements on cystic fibrosis (CF) drug...

Pencil Beam Radiation Offers New Therapy Option for Lung Cancer Patients

October 19, 2010 7:32 am | by Bio-Medicine.Org | News | Comments

HOUSTON, Oct. 19 /- Pencil beam scanning technology, an even more advanced and targeted form of radiation treatment known as proton therapy, is now being used to treat patients with lung cancer at The University of Texas MD Anderson Cancer Center.   Proton therapy derives its...

Advertisement

Mylan to Appeal Court Decision in Generic Paroxetine Hydrochloride CR Case

October 18, 2010 4:32 pm | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Oct. 18 /- Mylan Inc. (Nasdaq: MYL ) today announced that its motion for a preliminary injunction against GlaxoSmithKline and Apotex pertaining to generic Paxil CR was denied at a hearing today in the U.S. District Court for the District of New Jersey. The company believes...

New 2010 European Resuscitation Council Guidelines published

October 18, 2010 1:34 pm | by EurekAlert | News | Comments

(Elsevier) Elsevier announces the publication of the 2010 European Resuscitation Council Guidelines in the journal Resuscitation. These guidelines are based on an extensive international review of all the science supporting cardiopulmonary resuscitation (CPR), the 2010 International...

A new order for CPR, spelled C-A-B

October 18, 2010 6:31 am | by EurekAlert | News | Comments

(American Heart Association) The 2010 AHA Guidelines for CPR and ECC update the 2005 guidelines. When administering CPR, immediate chest compressions should be done first. Untrained lay people are urged to administer hands-only CPR (chest compressions only).

Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010

October 17, 2010 12:32 pm | by Bio-Medicine.Org | News | Comments

SAN CARLOS, Calif., Oct. 17 /- Nektar Therapeutics (Nasdaq: NKTR ) today presented new preclinical data demonstrating that NKTR-181, a mu-opioid analgesic with a novel molecular structure, dramatically reduces abuse liability while providing analgesia comparable to oxycodone and morphine....

Syndax Pharmaceuticals Announces Issuance of UK Patent for Entinostat

October 15, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Oct. 15 /-  Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced the UK Intellectual Property Office allowed application GB0907347.9 entitled N-(2-aminophenyl)-4-[N-(pyridine-3-YL)-methoxycarbonyl-aminomethyl]-benzamide (MS-275)...

Cantel Medical Corp. Launches New Medical Face Mask Addressing Issue of Fit

October 15, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

LITTLE FALLS, N.J., Oct. 15 /- Cantel Medical Corp. (NYSE: CMN ), announced today the launch of a new, unique design of medical face masks - the SecureFit™ series by Crosstex International, a Cantel subsidiary and a leading U.S. manufacturer of medical face masks. The...

Mylan Receives Approvals for Generic Versions of Hyzaar® and Cozaar®

October 15, 2010 4:31 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH, Oct. 15 /- Mylan Inc. (Nasdaq: MYL ) today announced that its subsidiary Mylan Pharmaceuticals Inc. received final approvals from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Applications (ANDAs) for the generic versions of Hyzaar® Tablets, 50...

Southeastern Michigan Gets First Ever FDA Approved Device That Destroys Fat Cells ... Without Surgery

October 15, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

SHELBY TOWNSHIP, Mich., Oct 14 /- Allure Medical Spa, first in Michigan with the new FDA approved Coolsculpting™ by Zeltiq. Great news for men and women dealing with exercise and diet-resistant fat in areas like the tummy, love handles and back rolls! Allure Medical Spa of Shelby...

New Survey Highlights Immediate Need for Anesthesia Information Management Systems

October 14, 2010 12:31 pm | by Bio-Medicine.Org | News | Comments

ATLANTA, Oct. 14 /- A new survey highlights the need for Anesthesia Information Management Systems (AIMS) with a full 91 percent of respondents indicating that access to day-of-surgery data is Extremely Important or Important to optimally manage their anesthesia department.  More...

Scientists assess new vaccines to improve health of African children

October 14, 2010 7:31 am | by EurekAlert | News | Comments

(University of Liverpool) Scientists at the University of Liverpool, in partnership with the Malawi Ministry of Health, are investigating the effectiveness of new vaccines developed to protect children from pneumonia and diarrhoea.

Consumer Reports Flu Poll: Approximately Three Out of 10 Health Care Workers 'Living in a Bubble,' Not Getting Flu Vaccine

October 14, 2010 3:31 am | by Bio-Medicine.Org | News | Comments

YONKERS, N.Y., Oct. 14 /PRNewswire-USNewswire/ -- A new Consumer Reports Health poll reveals a disconcerting proportion of "at risk" groups who will not get the flu vaccine this year.  Of most concern, only 40% of Americans in the "work risk" category—meaning those who care for...

Yoga alleviates pain and improves function in fibromyalgia patients

October 13, 2010 9:31 pm | by EurekAlert | News | Comments

(Elsevier Health Sciences) Fibromyalgia (FM) is a debilitating condition affecting 11 million individuals in the US alone. Drug therapies are generally only 30 percent effective in relieving symptoms and 20 percent effective in improving function. Standard care currently includes...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading